New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For AAPL;JPM;RDSA;NVS;BKS;WDC;GD;VIA;VIAB;BLK;MPC From The Last 14 Days
Check below for free stories on AAPL;JPM;RDSA;NVS;BKS;WDC;GD;VIA;VIAB;BLK;MPC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | all recent news | >>
April 22, 2014
09:38 EDTAAPLActive equity options trading on open
Subscribe for More Information
09:16 EDTNVSOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Netflix (NFLX), up 8%... Harley-Davidson (HOG), up 7%... PLX Technology (PLXT), up 8%... Illinois Tool (ITW), up 2.3%... Comcast (CMCSA), up 1%... McDonald's (MCD), up 0.6%. ALSO HIGHER: Allergan (AGN), up 17% after Valeant (VRX) confirms proposal to combine with the company for $48.30 and 0.83 shares of stock. Valeant is up 5% following its confirmation of the news that broke last night... GlaxoSmithKline (GSK), up 4.5% after agreeing to sell oncology products for $14.5B to Novartis (NVS) and buy Novartis' Vaccines business, currently excluding its flu business, for $7.1B plus royalties. Novartis shares trading in New York are also up 1% following the deals... Revance Therapeutics (RVNC), up 20% after announcing positive results from RT002 Phase 1/2 study... Facebook (FB), up 2% following upgrade at Credit Suisse. DOWN AFTER EARNINGS: Xerox (XRX), down 4%... Lexmark (LXK), down 4.8%. ALSO LOWER: Allison Transmission (ALSN), down 4% after filing to sell 25M shares for holders... FireEye (FEYE), down 2.9% after filing to sell 13.3M shares of common stock for holders... Bebe stores (BEBE), down 16% after reporting preliminary Q3 losses that were steeper than the consensus estimate.
07:50 EDTNVSNovartis CEO Jimenez says bolt-on-buys still could occur, Reuters says
Subscribe for More Information
07:48 EDTNVSGlaxoSmithKline to host conference call
Subscribe for More Information
07:46 EDTNVSGlaxo thinks Novartis agreement could mean future disposals, Reuters says
Subscribe for More Information
07:41 EDTNVSNovartis to host conference call
Subscribe for More Information
07:27 EDTBLKBlackRock names former HSBC employee senior strategist, Bloomberg says
Subscribe for More Information
07:26 EDTJPM, BLKInformation Management Network to hold a conference
Subscribe for More Information
07:25 EDTVIANatural E Creative Group to hold a summit
Subscribe for More Information
07:16 EDTAAPLiPhone sales could be hurt by fading phone subsidies, WSJ reports
Sales of Apple's (AAPL) iPhones may be further pressured as carriers make faster progress in transitioning customers away from subsidies, the Wall Street Journal reports. U.S. wireless carriers like T-Mobile US (TMUS) and AT&T (T) have been having more success than expected in moving customers to non-subsidy plans, a transition that could harm sales of expensive handsets such as the iPhone. Reference Link
07:11 EDTNVSEli Lilly to host conference call
Subscribe for More Information
06:42 EDTAAPLSamsung thinks $2.19B too costly for Apple patents, Bloomberg says
Samsung (SSNLF) feels that Apple's (AAPL) patent-infringement lawsuit of $2.19B is 57 times greater than what the South Korean company should pay if a jury deems that it infringed smartphone technology, reported Bloomberg. Reference Link
06:19 EDTJPMInvestment banks battling over stock trading, WSJ reports
Subscribe for More Information
05:38 EDTNVSEli Lilly acquires Novartis Animal Health for $5.4B in all-cash transaction
Subscribe for More Information
05:35 EDTNVSNovartis says transactions 'represent a transformation' for the company
The elements of the transaction with GSK (GSK) are inter-conditional and subject to approval by GSK shareholders. The Novartis (NVS) board unanimously believes that the transactions with GSK and the transaction with Lilly (LLY) are in the best interests of Novartis and the Novartis Shareholders as a whole. The transaction with Lilly is expected to close by the end of 1Q15 and the transaction with GSK is expected to close during the first half of 2015. The terms of the divestment of the Vaccines business would maximize the value of its pipeline, including Bexsero. The divestment of Animal Health would recognize the full value of the business. The transactions are expected to improve Novartis' sales and core operating income growth rates, while improving margins. Each of the transactions is projected to be value creating. The company commented, "These transactions represent a transformation for Novartis. We have leading positions in our core businesses in high-growth segments of healthcare. This will enable us to continue to build the world's most respected and successful healthcare company. Our strategic focus on science-based innovation and our global scale position the company well to meet the changes in the healthcare industry for the coming decade and beyond."
05:29 EDTNVSNovartis divests Animal Health Division to Eli Lilly for about $5.4B
Subscribe for More Information
05:26 EDTNVSNovartis OTC, GSK Consumer Healthcare form joint venture
Subscribe for More Information
05:23 EDTNVSNovartis divests Vaccines business to GSK for $7.1B
Novartis (NVS) has agreed to divest its Vaccines business to GSK (GSK), currently excluding its flu business, for $7.1B plus royalties. The $7.1B consists of $5.25B upfront and up to $1.8B in milestones. As a part of a value-maximization strategy in the context of the portfolio review, Novartis has initiated a separate sales process for its flu business.
05:20 EDTNVSNovartis to acquire GSK oncology products for $14.5B
Subscribe for More Information
April 21, 2014
16:01 EDTAAPLOptions Update; April 21, 2014
iPath S&P 500 VIX Short-Term Futures down 78c to 40.03. Option volume leaders: AAPL C GILD NFLX TSLA TWTR FB WLT according to Track Data.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use